Featured Content
Some of the best advice orthopedic surgeons have received has nothing to do with the operating room. From treating time…
The Latest
Every health system is being asked to make decisions about AI. Few leaders have the context they would like to guide those decisions. Fewer have had the chance to hear from the people who actually build it: How does a…
Presented by:
What 105 healthcare leaders say about the returns on outpatient growth—and what it takes to realize them Health systems and medical groups have shifted capital from inpatient facilities to ambulatory care, increasingly counting on outpatient growth to strengthen margins. But…
Presented by:
Enterprise server prices are up 8-5%, RAM-heavy builds are up 15-25%, and SSD lead times now run three to six months. That repricing has landed in the middle of a planning cycle already complicated by AI. Next-generation GPU racks draw…
An AI investment that saves FTEs is easy to defend. One that improves patient safety, clinician satisfaction or access to care is harder to put in front of a finance committee. One health system addressed this by naming both. Green…
Picture a perioperative program where supply chain decisions, physician preference and financial targets are debated from the same set of numbers rather than three separate ones. That alignment is what separates the systems capturing perioperative improvement from the ones still…
On Demand
Presented by:
- Dawn Perryman, Associate Vice President, Perioperative Supply Chain Solutions, Vizient, Inc.
- René Gurdián Jr., MBA, Vice President, SCM Data Analytics and Transformation, Ochsner Health
- Nattie Leger, MSN, RN, LSSBB, Vice President, Supply Chain Value & Clinical Performance, Ochsner Health
University of Rochester (N.Y.) Medicine researchers identified a potential biomarker that could help predict outcomes in patients with severe bone and joint infections. Researchers studied humanized mice and patient bone samples and found T cells in chronic Staphylococcus aureus infections…
Tampa, Fla.-based Joseph Spine Institute launched a Regenerative Therapy Center offering autologous adipose-derived cell therapies and platelet-rich plasma for spine and musculoskeletal care. The practice said the center will combine regenerative therapies with spine diagnosis, interventional pain management, sports medicine…
University of California Los Angeles researchers found little evidence supporting the use of six emerging peptides for musculoskeletal treatment, tissue recovery or performance. The researchers reviewed 565 studies examining BPC-157, TB-500, CJC-1295, MK-677, ipamorelin and GHK-Cu. More than two-thirds of…
GLP-1 medications are making more patients viable for surgery, but the muscle loss, bone changes and nutritional gaps that come with rapid weight loss may be working against the outcomes surgeons are optimizing for. Patients are arriving in surgeons’ offices…
A single number has defined osteoporosis diagnosis for more than three decades: the T-score, a measure of bone mineral density taken from a DEXA scan and codified by the World Health Organization. It is still the standard insurers use to…
Popular in Spine
Mandatory, measured, and coming fast: Getting cardiology ready for CMS changes
Presenters: Kenneth Civello, MD, MPH, FACC, FMOL HealthVicki Miller, DNP, RN, CPHQ, Lee HealthSunthosh V. Parvathaneni, MD, FACC, FHRS, University of Missouri/Mercy Hospital – SpringfieldRoy Davis, Mercy Health
Becker’s offerings
-
Events
Where healthcare leaders meet — see what’s coming up.
View All Events
-
Webinars
Explore and register for webinars across a wide variety of topics.
View All Webinars
-
Whitepapers
Gain valuable insights & knowledge from our leading industry experts.
View All Whitepapers
-
Podcasts
Listen to interviews and conversations on healthcare’s most pressing issues.
View All Podcasts
